Background. Careful selection of patients with colorectal peritoneal metastases (PM) for cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is crucial. It remains unknown whether the time of onset of colorectal PM (synchronous vs metachronous) influences surgical morbidity and survival outcomes after CRS with HIPEC. Methods. Patients with histologically proven colorectal PM who underwent CRS with HIPEC between February 2006 and December 2017 in two Dutch tertiary referral hospitals were retrospectively included from a prospectively maintained database. The onset of colorectal PM was classified as synchronous (PM diagnosed at the initiationalpresentation with colorectal cancer) or metachronous (PM diagnosed af...
BACKGROUND: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) are maximal...
The effect of cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with r...
AIM: Peritoneal metastases from colorectal cancer confer the worst survival among all metastatic sit...
Background. Careful selection of patients with colorectal peritoneal metastases (PM) for cytoreducti...
Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a ...
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS?+?HIPEC) can result in long...
Background This study aimed to compare treatment strategies and survival of patients with synchronou...
Introduction: Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) improve the surviv...
The prognosis of patients with peritoneally metastasized colorectal cancer has improved significantl...
The aim of this study was to compare the outcome of patients with peritoneal metastasis (PM) of colo...
Cytoreductive peritoneal surgery (CRS) associated with hyperthermic peritoneal chemotherapy (HIPEC) ...
Cytoreductive peritoneal surgery (CRS) associated with hyperthermic peritoneal chemotherapy (HIPEC) ...
Background: Peritoneal cancer index (PCI) >20 is often seen as a contraindication for cytoreducti...
[eng] Background and objectives Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy...
BACKGROUND: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) are maximal...
The effect of cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with r...
AIM: Peritoneal metastases from colorectal cancer confer the worst survival among all metastatic sit...
Background. Careful selection of patients with colorectal peritoneal metastases (PM) for cytoreducti...
Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a ...
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS?+?HIPEC) can result in long...
Background This study aimed to compare treatment strategies and survival of patients with synchronou...
Introduction: Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) improve the surviv...
The prognosis of patients with peritoneally metastasized colorectal cancer has improved significantl...
The aim of this study was to compare the outcome of patients with peritoneal metastasis (PM) of colo...
Cytoreductive peritoneal surgery (CRS) associated with hyperthermic peritoneal chemotherapy (HIPEC) ...
Cytoreductive peritoneal surgery (CRS) associated with hyperthermic peritoneal chemotherapy (HIPEC) ...
Background: Peritoneal cancer index (PCI) >20 is often seen as a contraindication for cytoreducti...
[eng] Background and objectives Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy...
BACKGROUND: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) are maximal...
The effect of cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with r...
AIM: Peritoneal metastases from colorectal cancer confer the worst survival among all metastatic sit...